Ongoing challenges in the diagnosis of hepatocellular carcinoma
Authors:
- 19 December 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 10 (4) , 451-463
Abstract
SUMMARYIn 2001, the European Association for the Study of the Liver (EASL) endorsed the possibility of achieving a non-invasive diagnosis of Hepatocellular Carcinoma (HCC) for the first time. Since then, various refinements of the criteria and techniques capable of achieving this diagnosis and the role of plasma and tissue oncomarkers have been reported in the literature and have been accepted to different extents in various geographical areas. Such tools can also potentially imply prognostic significance. The present article critically discusses some of the most relevant and debated challenges which have emerged in this field, including the role of contrast-enhanced ultrasound, and of hepatocyte-specific magnetic resonance contrast agents, the pitfall of transient hepatic attenuation differences, the reliability of biopsy and the status of biomarkers.Keywords
This publication has 98 references indexed in Scilit:
- Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomyJournal of Hepatology, 2012
- Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelinesJournal of Hepatology, 2012
- Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular CarcinomaLiver Cancer, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Hepatocyte-specific magnetic resonance Imaging contrast agentsHepatology, 2011
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †Hepatology, 2009
- Identification of metastasis-related microRNAs in hepatocellular carcinomaHepatology, 2008
- Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient SurvivalClinical Cancer Research, 2008
- GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinomaJournal of Hepatology, 2005